Online citations, reference lists, and bibliographies.

Current Understanding Of Synergistic Interplay Of Chitosan Nanoparticles And Anticancer Drugs: Merits And Challenges

Prameela Kandra, Hemalatha Padma Jyoti Kalangi
Published 2015 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Recent advances have been made in cancer chemotherapy through the development of conjugates for anticancer drugs. Many drugs have problems of poor stability, water insolubility, low selectivity, high toxicity, and side effects. Most of the chitosan nanoparticles showed to be good drug carriers because of their biocompatibility, biodegradability, and it can be readily modified. The anticancer drug with chitosan nanoparticles displays efficient anticancer effects with a decrease in the adverse effects of the original drug due to the predominant distribution into the tumor site and a gradual release of free drug from the conjugate which enhances drug solubility, stability, and efficiency. In this review, we discuss wider applications of numerous modified chitosan nanoparticles against different tumors and also focusing on the administration of anticancer drugs through various routes. We propose the interaction between nanosized drug carrier and tumor tissue to understand the synergistic interplay. Finally, we elaborate merits of drug delivery system at the tumor site, with emphasizing future challenges in cancer chemotherapy.
This paper references
10.1023/A:1012128907225
Chitosan and Chitosan/Ethylene Oxide-Propylene Oxide Block Copolymer Nanoparticles as Novel Carriers for Proteins and Vaccines
P. Calvo (2004)
10.1016/j.ejpb.2012.10.017
Anti-tumor efficacy of chitosan-g-poly(ethylene glycol) nanocapsules containing docetaxel: anti-TMEFF-2 functionalized nanocapsules vs. non-functionalized nanocapsules.
Daniel Torrecilla (2013)
10.1038/nrd1088
The dawning era of polymer therapeutics
R. Duncan (2003)
10.1200/JCO.2002.06.110
Clinical relevance of MGMT in the treatment of cancer.
S. Gerson (2002)
Daten Pharm Ind
Restmonomerenbestimmung
10.3322/caac.21166
Cancer statistics, 2013
R. Siegel (2013)
10.1016/S0032-3861(96)00780-X
A spectroscopic and viscometric study of the metal ion-induced gelation of the biopolymer chitosan
H. P. Brack (1997)
10.1016/0378-5173(93)90048-K
Conjugate of mitomycin C with N-succinyl-chitosan: In vitro drug release properties, toxicity and antitumor activity
Y. Song (1993)
10.2337/diab.37.2.246
New Approach for Oral Administration of Insulin With Polyalkylcyanoacrylate Nanocapsules as Drug Carrier
C. Damgé (1988)
10.1038/nmat2992
The Targeted Delivery of Multicomponent Cargos to Cancer Cells via Nanoporous Particle-Supported Lipid Bilayers
C. Ashley (2011)
10.1001/jama.1993.03500010088038
Immunotoxin therapy of cancer.
I. Pastan (1993)
10.1016/J.VACCINE.2006.11.034
Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination.
D. Zaharoff (2007)
10.1201/9780824744694-19
Target-Oriented Drug-Delivery Systems
V. Kumar (2002)
10.1016/0378-5173(83)90166-7
Pharmacokinetics and Distribution of a Biodegradable Drug-carrier
L. Grislain (1983)
10.3322/canjclin.42.1.7
Cancer statistics for african americans
C. Boring (1992)
10.1097/00000441-196107000-00060
Textbook of Medical Physiology
A. Guyton (1961)
Global requirements for medical applications of chitin and its derivatives
Mh Struszczyk (2006)
10.1002/jps.2600651217
Polymerized micelles and their use as adjuvants in immunology.
G. Birrenbach (1976)
10.1533/9781845695873
Handbook of hydrocolloids.
G. Phillips (2009)
10.1016/J.ENZMICTEC.2006.10.019
Shrimp biowaste fermentation with Pediococcus acidolactici CFR2182: Optimization of fermentation conditions by response surface methodology and effect of optimized conditions on deproteination/demineralization and carotenoid recovery
N. Bhaskar (2007)
10.1007/BF00877245
Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles
J. Kattan (2004)
Bioremediation of shrimp biowaste by using natural probiotic for chitin and carotenoid production an alternative method to hazardous chemical method.
K. Prameela (2010)
10.1038/nbt.1866
Intranasal delivery to the brain
Robert I. Henkin (2011)
10.1016/S0309-1740(01)00089-4
Quality properties of pork sausage prepared with water-soluble chitosan oligomer.
C. Jo (2001)
10.1093/JNCI/94.20.1537
Impact of reporting delay and reporting error on cancer incidence rates and trends.
L. Clegg (2002)
10.1016/J.BIOMATERIALS.2004.07.047
Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes.
S. Balthasar (2005)
10.1002/jps.2600731103
Characterization of polyacryl starch microparticles as carriers for proteins and drugs.
P. Artursson (1984)
10.1021/CR030441B
Chitosan chemistry and pharmaceutical perspectives.
M. Kumar (2004)
10.1126/science.8128245
Biodegradable long-circulating polymeric nanospheres.
R. Gref (1994)
Studium der Mizellpolymerisation in Gegenwart niedermolekularer Arzneistoffe. Bindungsartvon inkorporierten niedermolekularen
H Kopf (1977)
Extraction of pharmaceutically important chitin and carotenoids from shrimp biowaste by microbial fermentation method
K Prameela (2010)
10.1533/9781845695873.849
Chitin and chitosan hydrogels
R.A.A. Muzzarelli (2009)
10.1016/j.biomaterials.2010.09.058
In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines.
Michael J. Heffernan (2011)
10.1002/jps.2600720933
Effect of the nonionic surfactant poloxamer 338 on the fate and deposition of polystyrene microspheres following intravenous administration.
S. Illum (1983)
10.1016/S0142-9612(03)00598-2
N-succinyl-chitosan as a drug carrier: water-insoluble and water-soluble conjugates.
Y. Kato (2004)
10.1038/35888
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
A. Fire (1998)
10.1038/sj.clpt.6100400
Nanoparticles in Medicine: Therapeutic Applications and Developments
L. Zhang (2008)
10.1158/1078-0432.CCR-05-1634
Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel.
N. Desai (2006)
10.1002/ijc.27528
Quantum dots hold promise for early cancer imaging and detection
Pericles Pericleous (2012)
Appl Microbiol Biotechnol
(2015)
10.1080/10408690390826473
Production, Properties, and Some New Applications of Chitin and Its Derivatives
J. Synowiecki (2003)
10.1111/j.1349-7006.1990.tb02559.x
Antimetastatic and Growth‐inhibitory Effects of N‐Acetylchitohexaose in Mice Bearing Lewis Lung Carcinoma
K. Tsukada (1990)
10.1080/10611860600833880
Polymer conjugates for drug targeting. From inspired to inspiration!
R. Duncan (2006)
10.1002/jps.21487
Lung-specific delivery of paclitaxel by chitosan-modified PLGA nanoparticles via transient formation of microaggregates.
R. Yang (2009)
Pharmacokinetics of pegylated liposomal doxorubicin : review of animal and human stud
SL Gerson (2003)
Cancer statistics. CA Cancer J Clin
A Jemal (2010)
10.1016/0378-5173(83)90113-8
Physicochemical characterization of polyacrylic nanoparticles
J. Kreuter (1983)
10.1016/S0008-6215(02)00021-6
Depolymerization of N-succinyl-chitosan by hydrochloric acid.
Y. Kato (2002)
10.1517/13543776.9.11.1499
Targeted drug delivery
Jeffrey K. Mills (1999)
Chitosan chemistry and pharmaceutical perspective
Ravi KumarMNV (2004)
10.1016/j.jconrel.2007.12.014
Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
J. Kim (2008)
10.1016/j.addr.2008.08.005
Active targeting schemes for nanoparticle systems in cancer therapeutics.
J. D. Byrne (2008)
N4-Behenoyl-1-beta-D-arabinofuranosylcytosine as a potential new antitumor agent.
M. Aoshima (1977)
10.3322/caac.20073
Cancer Statistics, 2010
A. Jemal (2010)
10.1200/JCO.2007.15.2553
Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival.
D. Kwekkeboom (2008)
10.1016/S0169-409X(02)00044-3
Nanoparticles in cancer therapy and diagnosis.
I. Brigger (2002)
10.1016/S0168-3659(03)00327-4
N-acylated chitosan: hydrophobic matrices for controlled drug release.
C. Le Tien (2003)
10.1038/nri3174
Targeting natural killer cells and natural killer T cells in cancer
E. Vivier (2012)
10.3322/canjclin.52.1.8
American Cancer Society Guidelines for the Early Detection of Cancer
R. Smith (2002)
10.1073/pnas.79.2.626
A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies.
A. Trouet (1982)
10.1016/0168-3659(96)01372-7
Drug release and antitumor characteristics of N-succinyl-chitosanmitomycin C as an implant
Y. Song (1996)
10.1016/S0168-3659(00)00356-4
Biological characteristics of lactosaminated N-succinyl-chitosan as a liver-specific drug carrier in mice.
Y. Kato (2001)
10.1038/nmat3049
Nanoparticles that communicate in vivo to amplify tumour targeting.
G. von Maltzahn (2011)
10.3322/canjclin.56.2.106
Cancer Statistics, 2006
A. Jemal (2006)
10.3390/molecules16108504
Antibacterial Characteristics and Activity of Water-Soluble Chitosan Derivatives Prepared by the Maillard Reaction
Y. Chung (2011)
Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier systems for uptake in lymphocytes
S Balthasar (2005)
10.3322/canjclin.39.6.399
Cancer statistics
N. Dubrawsky (1989)
10.1038/nrc903
Ligand-targeted therapeutics in anticancer therapy
T. Allen (2002)
10.1053/J.SEMINONCOL.2004.08.001
Advantages of liposomal delivery systems for anthracyclines.
T. Allen (2004)
10.1146/ANNUREV.BIOENG.9.060906.152025
Nanotechnology applications in cancer.
Shuming Nie (2007)
10.1002/9783527610419.NTLS0060
Conventional Chemotherapeutic Drug Nanoparticles for Cancer Treatment
L. Serpe (2007)
10.1200/JCO.2003.10.589
Imatinib as a paradigm of targeted therapies
B. Druker (2003)
10.1038/nrc3239
The blockade of immune checkpoints in cancer immunotherapy
D. Pardoll (2012)
10.2147/IJN.S3061
Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer
E. Miele (2009)
10.1016/J.PROGPOLYMSCI.2006.06.001
Chitin and chitosan: Properties and applications
M. Rinaudo (2006)
12. Global Requirements for Medical Applications of Chitin and its Derivatives
M. H. Struszczyk (2006)
10.1080/026520400288427
Gelatin nanoparticles by two step desolvation--a new preparation method, surface modifications and cell uptake.
C. Coester (2000)
Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours.
A. Gabizon (1997)
10.1007/PL00000584
Human enzymatic activities related to the therapeutic administration of chitin derivatives
R. Muzzarelli (1997)
10.1016/j.tibtech.2012.04.008
Colloidal systems for drug delivery: from design to therapy.
Mariana Beija (2012)
10.7150/thno.3463
Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy
M. Yu (2012)
10.1021/BM010083R
Preparation of chitosan gel beads by ionotropic molybdate gelation.
L. Dambies (2001)
10.1111/J.0818-9641.2004.01280.X
Adjuvant synergy: the effects of nasal coadministration of adjuvants.
S. Moschos (2004)
10.1039/C39800001153
Formation of branched-chain, soluble polysaccharides from chitosan
L. D. Hall (1980)
10.2147/IJN.S17296
Recent advances of chitosan nanoparticles as drug carriers
J. Wang (2011)
10.1038/nrc887
How acute promyelocytic leukaemia revived arsenic
J. Zhu (2002)
10.1002/jps.2600580916
Epoxy resin beads as a pharmaceutical dosage form. I. Method of preparation.
S. C. Khanna (1969)
10.1038/nrc3237
Combining immunotherapy and targeted therapies in cancer treatment
M. Vanneman (2012)
10.1002/cncr.23228
Racial disparities in cancer therapy
C. Gross (2008)
10.1016/S0378-5173(01)00955-3
Polymer-cysteamine conjugates: new mucoadhesive excipients for drug delivery?
C. Kast (2002)
10.2165/00003088-200342050-00002
Pharmacokinetics of Pegylated Liposomal Doxorubicin
A. Gabizon (2003)
Intranasal delivery to brain Effect of the nonionic surfactant poloxamer 338 on the fate and deposition of polystyrene microspheres following intravenous administration
L Henkin R480 Illum (1983)
10.1016/S1359-6349(09)71352-7
6631 Gemcitabine and Oxaliplatine combination chemotherapy for metastatic well differentiated neuroendocrine carcinomas: a single-centre experience
Philippe A. Cassier (2009)
10.1002/jps.2600751009
Disposition kinetics and oral bioavailability of vincamine-loaded polyalkyl cyanoacrylate nanoparticles.
P. Maincent (1986)
Nanomaterials for cancer therapy
C. Kumar (2006)
10.3109/03639048109055684
Development of Biodegradable and Injectable Latices for Controlled Release of Potent Drugs
R. Gurny (1981)
10.1038/nnano.2010.148
Bioorthogonal chemistry amplifies nanoparticle binding and enhances the sensitivity of cell detection.
J. Haun (2010)
Chitin and chitosan hydrogels. In: Phillips GO, Williams PA (eds) Handbook of hydrocolloids
RAA Muzzarelli (2009)
Bio-Efficiency of Paediococcus acidilactici ATCC 8042 for Recovery of Chitin and Carotenoids in the Fermentation of Shrimp Biowaste
Kandra Prameela (2010)
10.1016/S0142-9612(03)00108-X
Galactosylated chitosan as a synthetic extracellular matrix for hepatocytes attachment.
I. Park (2003)
10.1016/S0169-409X(01)00197-1
Chitosan for mucosal vaccination.
I. M. van der Lubben (2001)
Antitumor activity of chitosan oligosaccharides produced in ultrafiltration membrane reactor system
Y. Jeon (2002)
10.1038/nnano.2008.46
Nanogeometry: beyond drug delivery.
M. Ferrari (2008)
N4-Behenoyl-1-β-d-arabinofuranosylcytosine as a Potential New Antitumor Agent
Michiko Aoshima (1977)
10.1248/bpb.19.1170
In vivo drug release and antitumor characteristics of water-soluble conjugates of mitomycin C with glycol-chitosan and N-succinyl-chitosan.
M. Sato (1996)
10.1038/nrc3107
MicroRNA regulation by RNA-binding proteins and its implications for cancer
M. V. Kouwenhove (2011)
10.1002/jps.22798
Octreotide-modified N-octyl-O, N-carboxymethyl chitosan micelles as potential carriers for targeted antitumor drug delivery.
Aifeng Zou (2012)
Characterization of polyacryl starch microparticles suitable as carrier for proteins and drugs
P Arthursson (1984)
10.1016/S0065-2571(00)00013-3
The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting.
H. Maeda (2001)
10.1038/nbt876
Small-scale systems for in vivo drug delivery
David A. LaVan (2003)
10.1016/S0169-409X(00)00123-X
Polysaccharide colloidal particles as delivery systems for macromolecules.
K. Janes (2001)
10.1038/nrclinonc.2010.139
Delivering nanomedicine to solid tumors
R. Jain (2010)
10.1016/J.PROGPOLYMSCI.2009.04.001
Chitin and chitosan polymers: Chemistry, solubility and fiber formation
C. K. S. Pillai (2009)
10.1016/j.biomaterials.2009.05.052
pH-triggered injectable hydrogels prepared from aqueous N-palmitoyl chitosan: in vitro characteristics and in vivo biocompatibility.
Ya-Ling Chiu (2009)
10.1016/S0142-9612(00)00328-8
Chitosan accelerates the production of osteopontin from polymorphonuclear leukocytes.
H. Ueno (2001)
10.1200/JCO.2005.03.6046
Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors.
M. Kulke (2006)
10.1038/nrc706
Multidrug resistance in cancer: role of ATP–dependent transporters
M. Gottesman (2002)
10.1016/j.addr.2008.03.018
Magnetic nanoparticles in MR imaging and drug delivery.
C. Sun (2008)
10.1562/2004-07-20-RA-236.1
Enhancement of Laser Cancer Treatment by a Chitosan-derived Immunoadjuvant¶
W. Chen (2005)
10.1158/1078-0432.CCR-06-2053
Temozolomide as Monotherapy Is Effective in Treatment of Advanced Malignant Neuroendocrine Tumors
S. Ekeblad (2007)
10.1002/jps.2600590508
Bead polymerization technique for sustained-release dosage form.
S. C. Khanna (1970)
10.1002/cncr.24384
Gemcitabine and oxaliplatin combination chemotherapy for metastatic well‐differentiated neuroendocrine carcinomas
P. Cassier (2009)
10.2165/00003495-199700544-00005
Polyethylene Glycol-Coated (Pegylated) Liposomal Doxorubicin
A. Gabizon (2012)
Nanocarriers as an emerging platform for cancer therapy
S. Wise (2007)
10.1016/S0144-8617(96)00154-3
Design of quaternary chitosan conjugate having antennary galactose residues as a gene delivery tool
J. Murata (1997)
10.1016/S0142-9612(02)00005-4
Localized delivery of paclitaxel in solid tumors from biodegradable chitin microparticle formulations.
S. Nsereko (2002)
10.1016/S0008-6215(00)90359-8
Antitumor effect of hexa-N-acetylchitohexaose and chitohexaose.
K. Suzuki (1986)
10.1007/s00253-011-3651-2
Efficient use of shrimp waste: present and future trends
Prameela Kandra (2011)
Cancer statistics. CA Cancer J Clin
A Jamal (2006)
10.1248/cpb.31.175
Activation of 5'-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors.
A. Kono (1983)
10.1038/nrc2394
Paul Ehrlich's magic bullet concept: 100 years of progress
K. Strebhardt (2008)
10.1504/IJNM.2009.028116
Electrochemically deposited metal nanoparticles for enhancing the performance of microfluidic MEMS in biochemical analysis
A. D. Bani-Yaseen (2009)



This paper is referenced by
10.1016/j.bmcl.2020.127134
The EZMTT cell proliferation assay provides precise measurement for drug combinations and better correlation between in vitro and in vivo efficacy.
Jingjing Rui (2020)
10.3762/bjnano.7.178
Chitosan-based nanoparticles for improved anticancer efficacy and bioavailability of mifepristone
H. Zhang (2016)
10.1007/978-1-4939-3634-2_7
Targeting Cancer Using Nanocarriers
Dalit Landesman-Milo (2016)
10.1038/srep38348
In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapy
H. Han (2016)
10.1016/J.PMATSCI.2019.01.001
Electrophoretic deposition of chitosan-based composite coatings for biomedical applications: A review
Egemen Avcu (2019)
10.1002/slct.201801331
A Regioselective Synthesis of Carbazole‐Appended Dispiropyrrolothiazoles/Pyrrolidines: Synthesis, Computational Studies and In Vitro Anticancer Activity
Kripalaya Ratheesh Arya (2019)
10.1002/PAT.4375
Overview on natural hydrophilic polysaccharide polymers in drug delivery
Fatemeh Abedini (2018)
10.1016/j.ijbiomac.2018.05.205
Modified chitosan-based bioactive material for antimicrobial application: Synthesis and characterization.
Elton Marks de Araújo Braz (2018)
10.1007/978-981-10-7434-9_11
Recovery of Nutraceuticals from Agri-Food Industry Waste by Lactic Acid Fermentation
Lyned D. Lasrado (2018)
10.1088/1757-899X/225/1/012266
Eco-Friendly Extraction of Biopolymer Chitin and Carotenoids from Shrimp Waste
Kandra Prameela (2017)
10.1016/J.APSUSC.2016.10.015
Preparation of paclitaxel/chitosan co-assembled core-shell nanofibers for drug-eluting stent
Jing Tang (2017)
10.4028/www.scientific.net/NHC.25.32
Biosynthesis of Silver Nanoparticles from Eucalyptus corymbia Leaf Extract at Optimized Conditions
Munyao Joshua Sila (2019)
10.1039/c5ob02176f
Design, synthesis and anticancer activities of novel otobain derivatives.
Zhongzhou Li (2016)
10.1016/j.foodchem.2017.05.097
Next generation nutraceutical from shrimp waste: The convergence of applications with extraction methods.
Kandra Prameela (2017)
10.4238/gmr15048860
Influence of chitosan nanoparticle-mediated C-erbB-2 gene silencing on invasion and apoptosis of Hep-2 cells.
W. Liu (2016)
Semantic Scholar Logo Some data provided by SemanticScholar